Patients want to access cross-border health services when treatment is
not available in their home country, when it is better managed
elsewhere, or, as is the case in many border areas, when the nearest
available care is in another Member State. Currently, cross-border
healthcare accounts for approximately 1% of the overall EU public health
spending – around €10 billion per year.
This international symposium provides a platform for a constructive debate on the current state of the Cross-Border Healthcare Directive’s implementation throughout Europe as well as on the necessary actions that need to be taken to reduce health inequalities and facilitate access to better and safer care for patients in the EU.
This international symposium provides a platform for a constructive debate on the current state of the Cross-Border Healthcare Directive’s implementation throughout Europe as well as on the necessary actions that need to be taken to reduce health inequalities and facilitate access to better and safer care for patients in the EU.